Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial

By afschroeder • November 12, 2025

Diggs MR, Chu SM, Fitch KV, Olefsky M, Watanabe MG, Erlandson KM, Lu AB, Bloomfield GS, Currier JS, Curran A, Eckard AR, Smith GHR, Sponseller CA, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Foldyna B, Taron J, Karady J, Zanni MV, Douglas PS, Ribaudo HJ, Lu MT, Grinspoon SK. Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial. AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004401. Epub ahead of print. PMID: 41217428.

Tags: atherosclerotic cardiovascular disease, cardiovascular disease, Coronary CTA, health-related quality of life, HIV, Infectious Diseases, Publications, Statins

Related Posts

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E,[...]

The HosA histone deacetylase regulates stress resistance, host cell interactions, and virulence in Aspergillus fumigatus

Liu H, Lee P, Vo A, Paul S, Phan QT, Lin J, Bruno VM, Stamnes MA, Moye-Rowley WS, Filler SG. The HosA histone deacetylase regulates[...]

The Medicine for a Changing Planet curriculum: a mixed methods evaluation

Benzekri NA, Tin AH, Judson SD, Ripp K, Xie M, Veidis E, Barry M, Rabinowitz P. The Medicine for a Changing Planet curriculum: a mixed[...]